Opioids for cancer pain - an overview of Cochrane reviews
Authors:
- 8 March 2017
- reference entry
- Published by Wiley
- Vol. 2017 (3)
Abstract
This is a protocol for a Cochrane Review (Overview). The objectives are as follows: To provide an overview of the analgesic efficacy of opioids in cancer pain, and to report on adverse events associated with their use.Keywords
This publication has 38 references indexed in Scilit:
- Association Between Analytic Strategy and Estimates of Treatment Outcomes in Meta-analysesJAMA, 2014
- Influence of trial sample size on treatment effect estimates: meta-epidemiological studyBMJ, 2013
- Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPCThe Lancet Oncology, 2012
- The Relationship Between Cancer Pain and Quality of Life in Patients Newly Admitted to Wuhan Hospice Center of ChinaAmerican Journal of Hospice and Palliative Medicine®, 2011
- Codeine, Ultrarapid-Metabolism Genotype, and Postoperative DeathNew England Journal of Medicine, 2009
- Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudesAnnals of Oncology, 2009
- Pharmacogenetics of cytochrome P4502D6: genetic background and clinical implicationEuropean Journal of Clinical Investigation, 2003
- Peak Plasma Concentrations After Oral MorphineJournal of Pain and Symptom Management, 1998
- The number needed to treat: a clinically useful measure of treatment effectBMJ, 1995
- RENAL FAILURE AND THE USE OF MORPHINE IN INTENSIVE CAREThe Lancet, 1985